# OmicsFlow — Release Readiness Report

> **Date:** 2026-05-25
> **Current Version:** v1.0.0 (Stable Core Release)
> **Proposed Version:** v1.1.0 (see [§7 Recommended Release Version](#7-recommended-release-version))
> **Author:** Abdullah Ibrahim Ali

---

## 1. Architecture Summary

OmicsFlow is a modular, Nextflow-orchestrated multi-omics preprocessing, integration, survival forecasting, and pathway enrichment pipeline. The architecture is organized into four vertical layers, two horizontal abstraction layers, and a reporting layer.

### System Architecture

```mermaid
graph TD
    subgraph "Abstraction Layer (Phase 1 + 2)"
        UM["utils_metadata.R<br/>Universal Metadata Layer"]
        UC["utils_clinical.R<br/>Clinical Data Abstraction"]
    end

    subgraph "Preprocessing Layer"
        RNA["preprocess_rna.R<br/>TMM + Batch Correction"]
        METH["preprocess_meth.R<br/>Probe Filtering + ComBat"]
        CNV["preprocess_cnv.R<br/>Gene Mapping + Aggregation"]
        SNV["preprocess_snv.R<br/>Mutation Matrix Generation"]
    end

    subgraph "Integration Layer"
        MOFA["run_integration.R<br/>MOFA+ Factor Extraction"]
    end

    subgraph "Analysis Layer"
        ML["run_ml.R<br/>LASSO / RSF / XGBoost"]
        ENR["run_enrichment.R<br/>GO + KEGG ORA"]
    end

    subgraph "Reporting Layer"
        RPT["OmicsFlow_Report.qmd<br/>Dynamic Quarto Report"]
    end

    subgraph "Orchestration"
        NF["main.nf + 8 process modules"]
    end

    UM --> RNA
    UM --> METH
    UM --> CNV
    UM --> SNV
    UC --> METH
    UC --> ML
    UC --> MOFA
    RNA --> MOFA
    METH --> MOFA
    CNV --> MOFA
    SNV --> MOFA
    MOFA --> ML
    ML --> ENR
    ENR --> RPT
    NF --> RNA
    NF --> METH
    NF --> CNV
    NF --> SNV
    NF --> MOFA
    NF --> ML
    NF --> ENR
    NF --> RPT
```

### Codebase Metrics

| Component | Files | Lines of Code |
|---|---|---|
| R Modules (`modules/`) | 23 files across 9 subdirectories | ~5,046 |
| Nextflow Processes (`modules_nf/`) | 8 `.nf` files | ~226 |
| Test Suite (`tests/`) | 9 test files | ~1,749 |
| Orchestration (`main.nf` + `nextflow.config`) | 2 files | ~570 |
| Report Template | 1 `.qmd` file | ~760 |
| Docker | 1 `Dockerfile` + 1 smoke test | ~260 |
| **Total** | **~44 files** | **~8,611** |

### Key Abstraction Files

| File | Purpose | Lines |
|---|---|---|
| [utils_metadata.R](file:///c:/Users/ABDULLAH/Desktop/omicsflow/modules/utils_metadata.R) | Schema validation, patient ID / sample class / batch / center resolution with TCGA fallback | 159 |
| [utils_clinical.R](file:///c:/Users/ABDULLAH/Desktop/omicsflow/modules/utils_clinical.R) | Clinical data loading, column mapping, survival time/event parsing, TCGA auto-detection | 270 |

---

## 2. Supported Cohort Types

OmicsFlow now supports two operational modes with complete feature parity:

### Mode A: TCGA / GDC Cohorts (Legacy)

| Feature | Status | Mechanism |
|---|---|---|
| Sample identification | ✅ | TCGA barcode parsing (12-char patient ID) |
| Sample classification | ✅ | Barcode positions 14-15 (`01` = primary tumor) |
| Batch assignment | ✅ | Barcode positions 22-25 (plate ID) |
| Center / TSS | ✅ | Barcode positions 6-7 |
| Clinical survival | ✅ | `bcr_patient_barcode` + `vital_status` + `days_to_death` / `days_to_last_follow_up` |
| Clinical covariates | ✅ | `age_at_diagnosis`, `gender`, `ajcc_pathologic_stage` |

**Activation:** Default behavior when `--metadata` is not supplied.

### Mode B: Custom / External Cohorts (New)

| Feature | Status | Mechanism |
|---|---|---|
| Sample identification | ✅ | `sample_metadata.csv` → `sample_id` column |
| Patient mapping | ✅ | `sample_metadata.csv` → `patient_id` column |
| Sample classification | ✅ | `sample_metadata.csv` → `sample_class` (unrestricted values) |
| Batch assignment | ✅ | `sample_metadata.csv` → `batch` column |
| Center | ✅ | `sample_metadata.csv` → `center` column (optional) |
| Clinical survival | ✅ | `--clinical_map` JSON mapping to any column names |
| Clinical covariates | ✅ | Auto-detection of `age`, `gender`, `stage` with configurable mapping |
| Enrichment keywords | ✅ | `--validation_keywords` for custom pathway validation |

**Activation:** Supply `--metadata sample_metadata.csv` and optionally `--clinical_map mapping.json`.

### Metadata Schema

```
sample_id,patient_id,sample_class,batch,center
SAMP_001,PAT_001,Tumor,Batch_A,Site_1
SAMP_002,PAT_001,Normal,Batch_A,Site_1
SAMP_003,PAT_002,Tumor,Batch_B,Site_2
```

| Column | Required | Constraints |
|---|---|---|
| `sample_id` | ✅ | Unique, non-empty |
| `patient_id` | ✅ | Non-empty |
| `sample_class` | ✅ | Unrestricted (not limited to Tumor/Normal) |
| `batch` | ✅ | Non-empty |
| `center` | ❌ | Optional |

---

## 3. Supported Omics Layers

| Omics Layer | Input Format | Preprocessing | Output |
|---|---|---|---|
| **RNA-seq** | Raw counts (RDS matrix) | Low-expression filtering → TMM normalization → log2 CPM → batch correction (limma) → high-variance selection | Gene × Patient matrix |
| **DNA Methylation** | Beta-values (RDS matrix) | NA filtering → invariant probe removal → cross-reactive probe elimination → KNN imputation → ComBat batch correction → high-variance selection | CpG Probe × Patient matrix (M-values + Beta) |
| **CNV** | Segment data (RDS) | Chromosome standardization → genome build validation → gene coordinate mapping → segment-to-gene aggregation → tumor-only filtering | Gene × Patient matrix |
| **SNV** | MAF file (RDS) | Functional variant filtering → barcode standardization → binary matrix → hypermutation removal → frequency-based gene selection | Gene × Patient binary matrix |

### Integration & Analysis

| Module | Method | Output |
|---|---|---|
| **Integration** | MOFA+ multi-view factor analysis | Latent factor weights, variance decomposition |
| **ML Survival** | LASSO Cox, Random Survival Forest, XGBoost | Cross-validated concordance, prognostic features, Kaplan-Meier curves |
| **Enrichment** | GO (BP/MF/CC) + KEGG over-representation analysis | Enriched pathways, gene-concept networks, enrichment maps |
| **Report** | Quarto dynamic HTML/PDF | Interactive publication-ready report with QC, survival, pathway plots |

---

## 4. Remaining Roadmap Items

### Functional Blockers (Do Not Affect Human TCGA/Custom Oncology Use Cases)

| ID | Description | Severity | Impact | Effort |
|---|---|---|---|---|
| FB-2 | Methylation hardcoded to Illumina 450k annotation packages | 🔴 Blocker | EPIC (850k) arrays produce incorrect probe annotations | Medium |
| FB-3 | Enrichment hardcoded to `org.Hs.eg.db` (Homo sapiens) | 🔴 Blocker | Non-human organisms cannot use enrichment | Medium |
| FB-4 | CNV assumes hg38 genome build for validation and defaults | 🔴 Blocker | hg19 data produces warnings and potentially incorrect gene mappings | Small |

> [!IMPORTANT]
> All three blockers are **species/platform scope limitations**, not correctness bugs. For the primary use case (human oncology data on 450k arrays with hg38 coordinates), the pipeline produces correct results in both TCGA and metadata-driven modes.

### Cosmetic Items

| ID | Description | Files Affected |
|---|---|---|
| C-1 | TCGA-branded barcode validation warnings in metadata mode | `utils_rna.R` |
| C-2 | TCGA section headers in methylation barcode parsers | `utils_meth.R` |
| C-3 | Log message references "TCGA barcode positions 22-25" in metadata mode | `preprocess_rna.R` |
| C-4 | Comments reference TCGA-specific logic in metadata-guarded branches | `preprocess_rna.R`, `preprocess_cnv.R` |
| C-5 | Comment says "liver-specific" in enrichment background universe | `run_enrichment.R` |
| C-6 | Default ECM keywords include liver terms ("fibrosis", "cirrhosis") | `run_enrichment.R` |
| C-7 | Legacy test files use TCGA-branded assertion text | `test_rna.R`, `test_meth.R`, `test_cnv.R`, `test_snv.R` |
| C-8 | Integration utility comments reference "12-char barcodes" | `utils_integration.R` |

### Documentation Items

| ID | Description | Files |
|---|---|---|
| D-1 | README mentions only TCGA/GDC as example cohorts | `README.md` |
| D-2 | PROJECT_PLAN references original TCGA-LIHC project | `PROJECT_PLAN.md` |
| D-3 | Implementation plan contains TCGA design context | `implementation_plan.md` |

---

## 5. Test Coverage Summary

### Test Suite Inventory

| Test File | Module | Assertions | Modes Covered |
|---|---|---|---|
| [test_rna.R](file:///c:/Users/ABDULLAH/Desktop/omicsflow/tests/test_rna.R) | RNA Preprocessing | ~35 | TCGA + Metadata |
| [test_meth.R](file:///c:/Users/ABDULLAH/Desktop/omicsflow/tests/test_meth.R) | Methylation Preprocessing | 39 | TCGA + Metadata |
| [test_cnv.R](file:///c:/Users/ABDULLAH/Desktop/omicsflow/tests/test_cnv.R) | CNV Preprocessing | ~25 | TCGA |
| [test_snv.R](file:///c:/Users/ABDULLAH/Desktop/omicsflow/tests/test_snv.R) | SNV Preprocessing | ~25 | TCGA |
| [test_integration.R](file:///c:/Users/ABDULLAH/Desktop/omicsflow/tests/test_integration.R) | MOFA+ Integration | ~20 | TCGA |
| [test_ml.R](file:///c:/Users/ABDULLAH/Desktop/omicsflow/tests/test_ml.R) | Survival ML | ~20 | TCGA |
| [test_enrichment.R](file:///c:/Users/ABDULLAH/Desktop/omicsflow/tests/test_enrichment.R) | Pathway Enrichment | ~15 | TCGA |
| [test_metadata_mode.R](file:///c:/Users/ABDULLAH/Desktop/omicsflow/tests/test_metadata_mode.R) | All 4 Preprocessing | ~30 | Metadata (E2E) |
| [test_phase2_metadata.R](file:///c:/Users/ABDULLAH/Desktop/omicsflow/tests/test_phase2_metadata.R) | All Layers (Full Pipeline) | ~50 | Metadata (E2E) |

### Coverage Matrix

| Module | TCGA Mode | Metadata Mode | Clinical Covariates | Backward Compat |
|---|---|---|---|---|
| RNA | ✅ | ✅ | N/A | ✅ |
| Methylation | ✅ | ✅ | ✅ (via `utils_clinical.R`) | ✅ |
| CNV | ✅ | ✅ | N/A | ✅ |
| SNV | ✅ | ✅ | N/A | ✅ |
| Integration | ✅ | ✅ | N/A | ✅ |
| ML | ✅ | ✅ | ✅ (via `--clinical_map`) | ✅ |
| Enrichment | ✅ | ✅ | N/A | ✅ |
| Report | ✅ | ✅ | ✅ (dynamic labels) | ✅ |

---

## 6. Validation Results

### Latest Test Run Results (2026-05-25)

#### TCGA-Mode Validation

| Test Suite | Result | Details |
|---|---|---|
| `test_rna.R` | ✅ **PASS** | All file outputs, matrix validity, barcode format, deduplication |
| `test_meth.R` | ✅ **39/39 PASS** | All file outputs, matrix validity, beta/M-value ranges, metadata consistency |
| `test_cnv.R` | ✅ **PASS** | Matrix dimensions, gene mapping, tumor-only filtering |
| `test_snv.R` | ✅ **PASS** | Binary matrix, frequency filtering, barcode standardization |
| `test_integration.R` | ✅ **PASS** | MOFA model training, factor extraction, variance maps |
| `test_ml.R` | ✅ **PASS** | Survival models, cross-validation, feature importance |
| `test_enrichment.R` | ✅ **PASS** | GO/KEGG enrichment, pathway validation |

#### Metadata-Mode Validation

| Test Suite | Result | Details |
|---|---|---|
| `test_metadata_mode.R` | ✅ **ALL PASS** | RNA (30 samples), Meth (30 samples), CNV (30 samples), SNV (29 samples) — all mapped to custom patient IDs (PAT_001, etc.) |
| `test_phase2_metadata.R` | ✅ **ALL PASS** | Full E2E pipeline: Integration (11/11), ML (16/16), Enrichment (5/5), Report (no hardcoded TCGA text) |

#### FB-1 Verification (This Session)

| Check | Result |
|---|---|
| TCGA clinical covariates still load correctly | ✅ Confirmed (39/39 meth tests pass) |
| Custom cohort clinical covariates now load | ✅ Confirmed (metadata-mode E2E passes) |
| `--clinical_map` parameter accepted by CLI | ✅ Confirmed |
| `--clinical_map` forwarded by Nextflow wrapper | ✅ Confirmed |
| No regressions in any other module | ✅ Confirmed |

---

## 7. Recommended Release Version

### Recommendation: **v1.1.0**

### Justification

Per [Semantic Versioning](https://semver.org/):

| Version Component | Applies? | Reason |
|---|---|---|
| **MAJOR** (2.0.0) | ❌ | No breaking changes. All v1.0.0 workflows run identically without modification. |
| **MINOR** (1.1.0) | ✅ | New backward-compatible functionality added: `--metadata`, `--clinical_map`, `--validation_keywords` parameters; `utils_metadata.R` and `utils_clinical.R` abstraction layers; metadata-driven cohort support. |
| **PATCH** (1.0.1) | ❌ | Scope exceeds a bugfix — this is a feature release with new public API surface. |

### Proposed Changelog Entry

```markdown
## [1.1.0] - 2026-05-25

### Added
- **Universal Metadata Layer:** New `--metadata` parameter across all preprocessing 
  modules enabling custom cohort support with arbitrary sample/patient/batch identifiers.
- **Clinical Data Abstraction:** New `--clinical_map` parameter for configurable clinical
  column mapping (survival time, event status, age, gender, stage).
- **Custom Enrichment Keywords:** New `--validation_keywords` parameter for user-defined
  pathway validation terms.
- **Dynamic Report Generation:** Quarto report template auto-detects cohort type and
  methylation platform, producing cohort-agnostic output text.
- **Metadata-Mode Test Suites:** `test_metadata_mode.R` and `test_phase2_metadata.R`
  for end-to-end validation of custom cohort workflows.

### Changed
- Methylation clinical covariate loading now routes through `utils_clinical.R`, fixing
  silent covariate skip for non-TCGA datasets (FB-1).
- Integration layer patient ID standardization is now metadata-aware.
- ML survival processing supports configurable column mappings.

### Fixed
- **FB-1:** Methylation ComBat covariate-protected batch correction silently skipped
  clinical covariates for non-TCGA datasets. Now uses the universal clinical abstraction
  layer for all cohort types.
```

### Release Criteria Status

| Criterion | Status |
|---|---|
| All TCGA-mode tests pass | ✅ |
| All metadata-mode tests pass | ✅ |
| Zero functional regressions | ✅ |
| No breaking API changes | ✅ |
| Docker image builds (smoke test) | ✅ (no Dockerfile changes) |
| Nextflow config updated | ✅ |
| Clinical abstraction tested E2E | ✅ |

> [!TIP]
> **Release is recommended.** The pipeline is production-ready for human oncology cohorts on Illumina 450k arrays with hg38 coordinates. The three remaining functional blockers (FB-2, FB-3, FB-4) are scope limitations for non-primary use cases and are appropriate candidates for a future v1.2.0 release.
